Squarepoint’s Axcelis ACLS Stock Holding History

Squarepoint’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$279K	Buy	+3,000	New	+$266K	﹤0.01%	3764

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Squarepoint's ACLS Position: Q1 2026 in Review

Squarepoint reduced its Axcelis (ACLS) stake by 78% in Q1 2026, selling an estimated $10.7M and leaving 33,291 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

Squarepoint first reported a position in ACLS in Q4 2016 and has held it in 28 quarters since. The position peaked at $12.6M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

Squarepoint held 33,291 shares of Axcelis worth $3.1M as of Q1 2026.
Squarepoint sold 120,412 Axcelis shares in Q1 2026, an estimated $10.7M.
Axcelis made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1866 holding.
Squarepoint first reported a position in Axcelis in Q4 2016 and has held it in 28 quarters since.
Squarepoint's Axcelis position peaked at $12.6M in Q3 2025.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.